Sponsor or institution
Clinical trials and research at Door Pharmaceuticals, LLC
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $620,863 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
HBV antiviral candidates that shut down virus replication and HBsAg production
A patient-friendly project testing new therapies aimed at stopping hepatitis B virus from multiplying and reducing the surface protein HBsAg to help the immune system clear the virus.
-
A new antiviral targeting the hepatitis B virus capsid protein
This study is testing a new treatment for people with chronic Hepatitis B that aims to better target the virus while reducing side effects, making it a potentially more effective option for managing the condition.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.